Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 13.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

VALEANT PHARMACEUTICALS INTERNATIONAL INC

WKN: A1C6JH  ISIN: CA91911K1021  Ticker-Symbol: BVF 
Branche
Pharma
Aktienmarkt
TSX-60
1-Jahres-Chart
VALEANT PHARMACEUTICALS INTERNATIONAL INC Chart 1 Jahr
1-Woche-Intraday-Chart
VALEANT PHARMACEUTICALS INTERNATIONAL INC 1-Woche-Intraday-Chart

Aktuelle News zur VALEANT PHARMACEUTICALS INTERNATIONAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
09.02. 34
CHICAGO, Feb. 9, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer
08.02. 9
MISSISSAUGA, Ontario, Feb. 8, 2012 /PRNewswire/ --Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet...
Mehr lesen zu:
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
08.02. 1
07.02. -
06.02. 35
CANONSBURG (dpa-AFX) - Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) on Monday said it has completed the divestiture of 1 percent clindamycin and 5 percent benzoyl peroxide gel...
Mehr lesen zu:
Valeant Completes Divestiture Of Generic Dermatology Products To Mylan
06.02. 9
MISSISSAUGA, Ontario, Feb. 6, 2012 /PRNewswire/ --Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of1% clindamycin and 5%...
Mehr lesen zu:
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
06.02. 10
PITTSBURGH, Feb. 6, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that it has successfully completed the acquisition of two dermatological products from Valeant...
Mehr lesen zu:
Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
02.02. 11
HONG KONG -- (Marketwire) -- 02/02/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Valeant Pharmaceuticals Int (USA) (NYSE: VRX) and The Dow Chemical Company (NYSE: DOW). Gain...
Mehr lesen zu:
2012 Economic Outlook - Report Highlights Valeant Pharmaceuticals Int (USA) and The Dow Chemical Company
02.02. 1
01.02. 1
01.02. 2
01.02. -
01.02. 70
MISSISSAUGA, Ontario, Feb.1, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Valeant has acquired Probiotica Laboratorios Ltda., a leader...
Mehr lesen zu:
Valeant Pharmaceuticals Acquires Probiotica in Brazil
31.01. 1
31.01. -
30.01. -
30.01. 1
30.01. 1
30.01. -
30.01. 1
Seite: 1 2 3 4 5 ... Weiter>>
107 Nachrichten in den letzten 6 Monaten